MSNBC on MSN1d
Not confident Trump will prevail: Scholar on his attempts to take Congress' power of the purse
Professor Deborah Pearlstein joins Morning Joe to discuss her column for the NYT outlining some of Trump’s actions ...
Researchers Studied a 11,000-Year-Old Rock Art Motif—and Uncovered a Fascinating Story
Deep in the Colombian Amazon region of Serrania De La Lindosa, a roughly 12-mile stretch of rock is covered in a vast ...
Healio2d
FDA receives biologics license application for apitegromab in spinal muscular atrophy
A Boston-area biopharmaceutical firm has submitted a biologics license application to the FDA for its investigational, fully ...
Scholar Rock’s (SRRK) “Outperform” Rating Reiterated at Wedbush
Wedbush restated their outperform rating on shares of Scholar Rock (NASDAQ:SRRK – Free Report) in a research note published on Wednesday,RTT News reports. They currently have a $47.00 target price on ...
SMA5d
Scholar Rock asks FDA to approve apitegromab for SMA
Scholar Rock is asking the U.S. Food and Drug Administration to approve apitegromab for people with spinal muscular atrophy.
Guitars, masks and defiance: Kenya’s rock and metal scene catches fire
After years in the wilderness, Kenyan bands like Irony Destroyed, Last Year’s Tragedy and Rash are clawing their way up the ...
LI scholar from Russia embraces US with love of learning, heavy metal
From Russia with love — of knowledge. A Long Island student who came to Mastic Beach as a child while knowing very little of ...
Scholar Rock: More Than Just An SMA Biotech With Q2 2025 Obesity Treatment Data
Scholar Rock submitted its BLA of apitegromab for the treatment of patients with Spinal Muscular Atrophy with a request for ...
Exchange Traded Concepts LLC Sells 82,792 Shares of Scholar Rock Holding Co. (NASDAQ:SRRK)
Exchange Traded Concepts LLC lessened its holdings in Scholar Rock Holding Co. (NASDAQ:SRRK – Free Report) by 81.4% during the 4th quarter, Holdings Channel.com reports. The firm owned 18,887 shares ...